文献速递乳腺乳腺X线US

临床与影像学特征能否帮助预测无上皮异型性的B3乳腺病变(B3a)的恶性风险?

Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)?
PubMed 文献 · Radiol Med · 2018-07-05

研究评估了153例影像引导下空心针活检诊断为B3a乳腺病变(74例乳头状瘤、51例放射状瘢痕、28例纤维上皮病变)手术切除后的组织学结果,11例(7%)升级为恶性,均为非高级别导管原位癌。病变大小>10 mm(OR=9.3832)和BI-RADS 4-5类(OR=12.6004)是升级为恶性的独立预测因素。

要点

  • B3a病变切除后恶性升级率低(11/153,7%),均为非高级别导管原位癌。
  • 病变大小>10 mm和BI-RADS 4-5类是升级为恶性的独立预测因素。
  • 活检后无残留微钙化与恶性风险降低相关(15/16[93.7%];p=0.0297)。

核心结论

  • B3a病变切除后恶性风险低;病变大小>10 mm和BI-RADS 4-5类可能是有用的恶性升级预测因素。

研究设计与样本

  • 评估153例影像引导下空心针活检诊断为B3a的乳腺病变(74例乳头状瘤、51例放射状瘢痕、28例纤维上皮病变),均行手术切除;评估所有B3a病变及亚类的恶性阳性预测值(PPV),多变量分析临床特征(年龄、乳腺癌家族史或个人史、症状)、诊断发现(影像方法、病变大小、最终BI-RADS分类)与最终切除结果的相关性。

诊断标准与关键数值

  • 全部B3a病变切除后恶性升级11/153(7%),均为非高级别导管原位癌。
  • 仅乳腺X线发现的病变升级3/21(14%),乳腺X线和超声均发现的病变升级7/44(16%)。
  • 病变大小>10 mm升级10/74(13.5%),BI-RADS 4-5类升级8/29(27.6%)。
  • 活检后无残留微钙化与恶性风险降低相关(15/16[93.7%];p=0.0297)。
  • 病变大小>10 mm(OR=9.3832;95%;p=0.0398)和BI-RADS 4-5类(OR=12.6004;95%;p=0.0006)是升级为恶性的独立预测因素。

临床应用与阅片要点

  • 对于影像引导下空心针活检诊断为B3a的病变,病变大小>10 mm和BI-RADS 4-5类可能提示升级为恶性的风险较高。
  • 活检后无残留微钙化可能与恶性风险降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate excision histology outcome of B3a lesions diagnosed at imaging-guided core biopsy and assess whether clinical and radiologic features may predict upgrade to malignancy.

METHODS: A total of 153 B3a lesions (74 papillomas, 51 radial scars and 28 fibro-epithelial lesions) that underwent surgical excision were assessed. PPV for malignancy in all B3a lesions and specific for each sub-category was evaluated. Multivariate analysis was conducted to identify association between clinical (age, family or personal history of breast cancer, symptoms), diagnostic findings (imaging modality, lesion size, final BI-RADS category) and final excision outcome.

RESULTS: Eleven (7%) of 153 B3a lesions were upgraded to malignancy. All carcinomas diagnosed on excision were non-high grade DCIS. Following features were significantly associated with malignancy: lesions identified only on mammography (3/21; 14%), both mammography and ultrasound (7/44; 16%), lesion size > 10 mm (10/74; 13.5%) and BI-RADS category 4-5 (8/29; 27.6%). The absence of residual microcalcification after biopsy was associated with decreased risk for malignancy (15/16[93.7%]; p = 0.0297). Lesion size > 10 mm (OR = 9.3832; 95%; p = 0.0398) and BI-RADS category 4-5 (OR = 12.6004; 95%; p = 0.0006) were found to be independent predictors of upgrade to malignancy.

CONCLUSIONS: B3a lesions are associated with low risk of malignancy at excision. Lesion size > 10 mm and BI-RADS 4-5 category may represent useful predictors of upgrade to malignancy.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Bednarova I, Londero V, Linda A, et al. Do clinical and radiologic features help predict malignancy of B3 breast lesions without epithelial atypia (B3a)? Radiol Med. 2018. PMID: 29974332. doi:10.1007/s11547-018-0914-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。